Experiment 688644

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismPrunus africana (ROSACEAE)
CitationLOWE,FC: FAGELMAN,E:. (1999). PHYTOTHERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: AN UPDATE.. 53(4)
Amount utilized
Compound isolated
DiseaseA 2-MONTH OPEN-LABEL TRIAL UTILIZING A 100-MG DAILY DOSAGE OF P. AFRICANA (TADENAN). THE IPSS WAS 16.17 +/- 3.68 AT BASELINE AND 9.71 +/- 4.57 AT THE END OF TREATMENT; THIS 40% REDUCTION IN SYMPTOM SCORES WAS STATISTICALLY SIGNIFICANT (P<0.0125). MEAN PEAK URINARY FLOW RATES WERE 10.97 +/- 3.58 ML/S AT BASELINE AND 13.07 +/- 5.56 ML/S AT THE END OF THERAPY (P<0.001). NO SIDE EFFECTS WERE IDENTIFIED IN THE STUDY GROUP. OBVIOUSLY, THIS UNCONTROLLED STUDY ONLY SUGGESTS A BENEFIT OF THIS AGENT. NO FURTHER CONCLUSIONS CAN BE MADE FROM THIS STUDY.
Dose amount100.0 MG
Number4
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractCHCL3 EXT
GenderMALE